Effect of a 12-month Pharmaceutical Care Program on Control of Severe Asthma
Effect of a 12-month Pharmaceutical Care Program on Severe Asthma Patient. A Randomized Clinical Trial
Sponsor: Conselho Nacional de Desenvolvimento Científico e Tecnológico
This NA trial investigates Asthma and Quality of Life and is currently completed. Conselho Nacional de Desenvolvimento Científico e Tecnológico leads this study, which shows 6 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Oct 2023 — Jul 2024 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jan 2021 — Oct 2023 [monthly]
Unknown Status NA
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status NA
First recorded
Aug 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Federal University of Bahia
For direct contact, visit the study record on ClinicalTrials.gov .